Heavy metals and cardiovascular disease: Results from the national health and nutrition examination survey (NHANES) 1999-2006

Angiology

Volumn 62, Issue 5, 2011, Pages 422-429

  Agarwal, Shikhar ^a   Zaman, Tarique ^a   Murat Tuzcu, E ^a   Kapadia, Samir R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

antimony; cadmium; cardiovascular disease; cerebrovascular disease; cobalt; heavy metals; lead; tungsten

Indexed keywords

ANTIMONY; ARSENIC; BARIUM; BERYLLIUM; CADMIUM; CESIUM; COBALT; LEAD; MOLYBDENUM; PLATINUM; THALLIUM; TUNGSTEN; URANIUM;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIATOR; MEDICAL HISTORY; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; NUTRITION; QUESTIONNAIRE; URINARY EXCRETION;

ADULT; AGED; CADMIUM; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LEAD; MALE; MIDDLE AGED; NUTRITION SURVEYS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; UNITED STATES;

EID: 79957492697     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319710395562     Document Type: Article

References (34)

1. Agency for toxic substances and disease registry. CERCLA Priority list of hazardous substances, 2005. http://www.atsdr.cdc.gov.cercla. Accessed July 25, 2010.
2. Hoffmann D., Hoffmann I., El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol. 2001 ; 14 (7). 767-790. (Pubitemid 32663874)
3. Loh HS Cigarette smoking and the pathogenesis of atherosclerosis-a hypothesis. Ir J Med Sci. 1973 ; 142 (4). 174-178.
4. Navas-Acien A., Selvin E., Sharrett R., Calderon-Aranda E., Silbergeld E., Guallar E. Lead, cadmium, smoking and increased risk of peripheral arterial disease. Circulation. 2004 ; 109 (25). 3196-3201.
5. Carroll RE The relationship of cadmium in the air to cardiovascular disease death rates. JAMA. 1966 ; 198 (3). 267-269.
6. Ponteva M., Elomaa I., Bäckman H., Hansson L., Kilpiö J. Blood cadmium and plasma zinc measurements in acute myocardial infarction. Eur J Cardiol. 1979 ; 9 (5). 379-391. (Pubitemid 9152071)
7. Adamska-Dyniewska H., Bała T., Florczak H., Trojanowska B. Blood cadmium in healthy subjects and in patients with cardiovascular diseases. Cor Vasa. 1982 ; 24 (6). 441-447. (Pubitemid 13148732)
8. Staessen JA, Buchet JP, Ginucchio G., et al. Public health implications of environmental exposure to cadmium and lead: an overview of epidemiological studies in Belgium. Working Groups. J Cardiovasc Risk. 1996 ; 3 (1). 26-41. (Pubitemid 26183646)
9. Peters J.L., Perlstein TS, Perry MJ, McNeely E., Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environ Res. 2010 ; 110 (2). 199-206.
10. http://www.cdc.gov/nchs/nhanes.htm. Accessed March 2, 2010.
11. Pirkle J.L., Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR Exposure of the US population to environmental tobacco smoke: the third national health and nutrition examination survey, 1988 to 1991. JAMA. 1996 ; 275 (10). 1233-1240. (Pubitemid 26118496)
12. Levey AS, Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation classification and stratification [published erratum appears in Ann Intern Med. 2003;139:605]. Ann Intern Med. 2003 ; 39 (2). 920-929.
13. Coresh J., Selvin E., Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007 ; 298 (17). 2038-2047. (Pubitemid 350074801)
14. Selvin S., Manzi J., Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007 ; 50 (5). 918-926. (Pubitemid 350122815)
15. http://www.cdc.gov/niosh/topics/ABLES. Accessed November 17, 2010.
16. http://www.osha.gov/SLTC/cadmium/index.html. Accessed November 17, 2010.
17. Agency for toxic substances and disease registry. Toxicological profile for lead. Atlanta, GA: US Department of Health and Human Services. Public health service ; 1999.
18. Agency for toxic substances and disease registry. Toxicological profile for cadmium. Atlanta, GA: US Department of Health and Human Services. Public health service ; 1999.
19. Jarup L., Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol. 2009 ; 238 (3). 201-208.
20. Sharrett AR, Ding J., Criqui MH, et al. Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2006 ; 186 (2). 441-447. (Pubitemid 44269074)
21. Gordon T., Kannel WB Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA. 1972 ; 221 (7). 661-666.
22. Heo Y., Parsons PJ, Lawrence DA Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol. 1996 ; 138 (1). 149-157. (Pubitemid 26159605)
23. Kaji T., Suzuki M., Yamamoto C., Mishima A., Sakamoto M., Kozuka H. Severe damage of cultured vascular endothelial cell monolayer after simultaneous exposure to cadmium and lead. Arch Environ Contam Toxicol. 1995 ; 28 (2). 168-172.
24. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995 ; 18 (2). 321-336.
25. Vaziri ND, Ding Y., Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther. 2001 ; 298 (2). 679-685. (Pubitemid 32673420)
26. Demontis MP, Varoni MV, Volpe AR, Emanueli C., Madeddu P. Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium. Br J Pharmacol. 1998 ; 123 (1). 129-135. (Pubitemid 28036981)
27. Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A., Atchison WD The vascular system as a target of metal toxicity. Toxicol Sci. 2008 ; 102 (2). 207-218. (Pubitemid 351404893)
28. Everett CJ, Frithsen IL Association of urinary cadmium and myocardial infarction. Environ Res. 2008 ; 106 (2). 284-286. (Pubitemid 351162984)
29. Tellez-Plaza M., Navas-Acien A., Crainiceanu CM, Guallar E. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect. 2008 ; 116 (1). 51-56.
30. Egwuogu H., Shendell DG, Okosun IS, Goodfellow L. The effect of urinary cadmium on cardiovascular fitness as measured by VO2 max in white, black and Mexican Americans. Environ Res. 2009 ; 109 (3). 292-300.
31. Navas-Acien A., Silbergeld EK, Sharrett R., Calderon-Aranda E., Selvin E., Guallar E. Metals in urine and peripheral arterial disease. Environ Health Perspect. 2005 ; 113 (2). 164-169. (Pubitemid 40326325)
32. Agency for toxic substances and disease registry (ATSDR). Toxicological profile for antimony. Atlanta, GA: US. Department of Health and Human Services, Public health service; 1992.
33. Agency for toxic substances and disease registry (ATSDR). Toxicological profile for cobalt. Atlanta, GA: US. Department of Health and Human Services, Public health service; 2004.
34. Agency for toxic substances and disease registry (ATSDR). Toxicological profile for tungsten. Atlanta, GA: US. Department of Health and Human Services, Public health service ; 2005.